Characterization of the natural killer cell cytokine response to antibody-coated tumor cells.
Year: 2004
Type: article
Abstract: The anti-tumor activity of recombinant monoclonal antibodies (mAb's) directed against tumor cell growth receptors has generally been considered to result from direct anti-proliferative effects, the induction of apoptosis within tumor cells, or possibly antibody (Ab)-dependent cellular cytotoxicity (ADCC) mediated against tumor targets.However, it remains unclear to what degree these mechanisms actually aid in the clearance of Ab-coated tumor cells in vivo.We show here that natural killer (NK) cells secrete a distinct profile of potent immune stimulatory cytokines in response to dual stimulation with Ab-coated tumor cells and interleukin (IL)-12.This response could not be duplicated by co-stimulation with other interleukins and was significantly enhanced in the presence of monocytes.Cytokine production was dependent upon synergistic signals mediated by the activating receptor for the Fc portion of IgG (FcγRIIIa) and the IL-12 receptor expressed on NK cells.Co-administration of Ab-coated tumor cells and IL-12 to BALB/c mice resulted in enhanced circulating levels of NK cell-derived cytokines with the capacity to augmentanti-tumor immunity.These findings suggest that, in addition to mediating cellular v Levels of activated Syk and extracellular signal-related kinase (Erk) were synergistically elevated in FcγRIIIa-+ IL-12-stimulated NK cells as compared to either stimulation alone.Moreover, inhibitor studies suggested that these molecules were critical for synergistic production of IFN-γ by dually stimulated NK cells.In contrast, chemical inhibition of Akt, or the MAPK family members p38 and Jnk, did not affect NK cytokine secretion, suggesting the activation of specific pathways for potent cytokine production.Interestingly, inhibition of lipid rafts within NK cell membranes abrogated the enhanced Erk activation and subsequent IFN-γ production, suggesting the importance of lipid raft signaling in mediating cytokine production.Confocal microscopy of NK cells confirmed co-localization of both FcγRIIIa and the IL-12R within areas of lipid raft micro-domains.These results suggest a novel interplay between the FcγRIIIa and the IL-12R signaling pathways that mediate potent cytokine production within NK cells.The phosphatase SHIP-1 is known to be critically involved in inhibitory Fc receptor (FcR) signaling within many cells of the immune system, most notably mast cells, B cells, and monocytes.However, its activity in the context of activating FcR's on NK cells (i.e.FcγRIIIa) is not clearly defined.We examined the receptor-induced SHIP-1 activity that may regulate NK cell cytokine production in response to FcR and IL-12R co-stimulation.Overexpression of wild-type SHIP-1 via retroviral transfection of primary human NK cells resulted in a 78% reduction of NK cell IFN-γ production.Interestingly, over-expression of a catalytic mutant form of SHIP-1 did not result in a similar reduction, suggesting the importance of the catalytic activity of vi SHIP-1 in its inhibitory effect on NK cytokine production.Purified splenic NK cells derived from SHIP-1-deficient mice and NK cell populations in vivo produced almost 10-fold greater amounts of IFN-γ in response to Ab-coated tumor cells plus IL-12 as compared to NK cells from wild-type littermates.In addition, activation of the MAPK family member Erk was significantly enhanced within SHIP-1-deficient NK cells.Further, inhibition of Erk activity by pharmacological inhibitors completely abolished IFN-γ production within both wild-type and SHIP-1-deficient NK cells.These results most likely reflect a normal physiological role for SHIP-1 in the down-regulation of FcγRIIIa-mediated NK cell activation.Taken together, these results enhance our overall understanding of the NK cell response to an important therapeutic target (Ab-coated tumor cells) and provide a rationale for our attempts to enhance NK cell function for therapeutic gain.vii
Author: Robin Parihar
Institution: The Ohio State University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2285424657
